RECRUITING

Non-invasive Central Venous Pressure Estimation in Pediatric Patients

Description

Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.

Study Overview

Study Details

Study overview

Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.

Non-invasive Central Venous Pressure Estimation in Pediatric Patients

Non-invasive Central Venous Pressure Estimation in Pediatric Patients

Condition
Central Venous Pressure
Intervention / Treatment

-

Contacts and Locations

Washington D.C.

Children's National Hospital, Washington D.C., District of Columbia, United States, 20010

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Weight less than 2.5kg at the time of enrollment.
  • * Bilateral external jugular veins not accessible due to vascular access or dressing.
  • * Bilateral skin lesion contraindicating neck Ultrasound
  • * Active bleeding
  • * Clinically unstable, per clinical assessment by attending physician and/or surgeon

Ages Eligible for Study

to 21 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Compremium AG,

Study Record Dates

2026-03-31